SlideShare a Scribd company logo
Radiation Therapy in Prostate 
Cancer 
Lokesh Viswanath M.D. 
Professor, Radiation Oncology, 
Kidwai Memorial Institute of Oncology 2014
Prostate Cancer 
• World wide : 
– Second most common cause of cancer 
– New Cases ~ 1.1 million (15%) 
– Developed countries ~ 70% 
– 307,000 deaths 
• Prostate cancer incidence 
– Lowest: 
• Asian populations 10.5 per 100,000 
• Eastern and South-Central Asia 4.5 per 100,000 
– Highest : 
• 111.6 Australia/New Zealand and 
• 97.2 per 100,000 Northern America
In India 
• Previously – thought - prevalence of prostate cancer in 
India is far lower compared to western countries 
• but … 
– increased migration rural to urban areas 
– changing life styles 
– increased awareness 
– easy access to medical facility 
….. 
– more cases of prostate cancer are being picked up 
– we are not very far behind the rate from western countries. 
– Current incidence rate of prostate cancer in India is ~ 10.66 
per 100000 population
Current India Data: 
• Prostate cancer: 
– 2nd leading site of - Delhi, Kolkatta, Pune and Thi'puram 
– 3rd leading site of Bangalore and Mumbai 
Projected cases of prostate cancer for selected time periods (2013, 2014, 2015 and 2020). 
ICD-10 Site name 2013 2014 2015 2020 
C61 Prostate 35,029 37,055 39,200 51,979
Prostate : Anatomy 
• Prostate 
– Accessory gland 
– Inverted Cone encompasses the p. urethra 
– Dense fibromuscular stroma 
– Surrounded by a capsule 
– 4 x 3 x 2cms 
– 8g 
• Prozimity to Rectum & U Bladder 
– Denonvilliers fascia 
• Blood supply 
– Inferior vesical 
– Mid rectal 
– Internal pudendal 
• Lymphatics 
– Internal iliac nodes 
– Sacral 
– Partly external iliac nodes 
Nervous supply 
– Neurovascular bundle 
• Lies on either side of the prostate on the rectum 
– Derived from the pelvic plexus - Important for erectile function.
Epidemiology 
• Risk factors 
– Increasing age 
– Family history 
– African-American 
– Dietary factors. 
• Race 
– Incidence doubled in African Americans compared to white Americans. 
• Genetics 
– Common among relatives with early-onset prostate cancer 
– Susceptibility locus 
• Chromosome 1, band Q24 
• Found in < 10% of prostate cancer patients 
• Nutritional factors - protective effect against prostate cancer 
– Reduced fat intake 
– Soy protein 
– Lycopene 
– Vitamin E 
– Selenium
Clinical Manifestations : Symptoms 
• Early state (organ confined) 
– Asymptomatic 
• Locally advanced 
– Obstructive voiding symptoms 
• Hesitancy 
• Intermittent urinary stream 
• Decreased force of stream 
– May have growth into the urethra or bladder neck 
– Hematuria 
– Hematospermia 
• Advanced (spread to the regional pelvic lymph nodes) 
– Edema of the lower extremities 
– Pelvic and perineal discomfort
Clinical Manifestations : 2 
• of Metastasis : 
– Most commonly to bone (frequently asymptomatic) 
• Can cause severe and unremitting pain 
– Bone metastasis 
• Can result in pathologic fractures or 
• Spinal cord compression 
– Visceral metastases (rare) 
– Can develop pulmonary, hepatic, pleural, peritoneal, and 
central nervous system metastases late in the natural 
history or after hormonal therapies fail.
Clinical Signs 
• Routine 
Clinical history and clinical examination 
Rectal examination 
• Signs: PR examination - Abnormal 
• ( +ve for Malignancy 25-50%) 
• Hard nodule / extremely firm 
• Evaluate for disease extension in 
– Lateral sulcus 
– superior
Presentation 
• Peripheral zone (PZ) 
– 70% of cancers 
• Transitional zone (TZ) 
– 20% 
– Some 
• TZ prostate cancers are relatively nonaggressive 
• PZ cancers are more aggressive 
– Tend to invade the periprostatic tissues.
Investigations 
Routine: Laboratory 
Complete blood cell count, 
blood chemistry 
Serum PSA (total, free, complex PSA:: ratio of Free : Total 
PSA < 0.2 - likely Prostate Ca. ) 
(Normal Age-Specific Limits for PSA - 
Plasma acid phosphatases (prostatic/total) 
Testosterone 
Other Experimental: 
RT PCR for mRNA of PSA & PSMA 
+ve - Extraprostatic – 72% 
-ve - Organ confined - 88%
Staging Tests 
1. Magnetic resonance imaging (MRI) – 
defn Apex, NV bundle, ano rectal wall, intra prostatic dises location, capsular extension, 
seminal vesicle involvement 
1. T2 axial / coronal : neurovascular bundle , penile bulb 
2. PZ - T2 Normal – high signal , Tumor – Low signal , T1 – Hemorrhage – Low 
signal intensity 
3. Extracapsular extension : focal, irregular capsular bulge, invasion of NV bundle, 
obliteration of rectoprostatic angle 
4. endorectal MRSI – MR spectroscopy : metabolic activity and extra capsular 
extension, seminal vesicle invasion : Increase coline 
2. Transrectal ultrasound (TRUS) : 
» Ca – variable echo, hyper – 69%, margin - poorly defined , 
3. Transrectal or transperineal biopsy : 
– 16 guage , 10 -18 core (base, apex, both lateral, mid, lat peripheral zone) 
– Core length 
4. Chest radiograph (high risk for metastatic disease) 
5. Computed tomography (CT) scans – pelvis node assesment 
6. Radionuclide bone scans : Indicated: PSA>20, Gleason score ≥8, Bone pain 
Other: 
1. PET/CT with 11C- Acetate - detecting microscopic +LN
Others : essential base line evaluation 
• Erectile function 
• Bowel : SI/LI/Rectum/Anal Sphincters 
• Bladder : Flow/rate
AJCC / TNM Stage Groupings Definitions
Pathology 
• Adenocarcinoma 95% - peripheral acinar glands 
• Other Histologic Subtypes 
– Periurethral duct carcinoma 
– transitional cell carcinoma 
– Ductal adenocarcinoma 
– Neuroendocrine tumors 
– Mucinous carcinoma 
– Sarcomatoid carcinoma 
– Endometrioid tumors 
– Adenoid cystic carcinoma 
– Sarcomas (leiomyosarcoma, rhabdomyosarcoma, or fibrosarcoma) 
– Carcinosarcoma 
– Primary lymphoma
Evaluation of the histologic grade ('G') 
GX: cannot assess grade 
G1: the tumor closely resembles normal tissue (Gleason 2–4) 
G2: the tumor somewhat resembles normal tissue (Gleason 5–6) 
G3–4: the tumor resembles normal tissue barely or not at all 
(Gleason 7–10)
Gleason score 
• histological patterns, emphasizing degree of 
glandular differentiation and relation to stroma 
• Histologic patterns 1 through 5 
• nine discrete scores (range, 2 to 10) 
• one of the strongest predictors of 
– biologic behavior in prostate cancer 
– invasiveness 
– metastatic potential 
– < 6
Prostate Cancer Risk Groups :- 
stage : PSA : Gleason score
Treatment options for prostate cancer 
• Observation alone 
• Radical prostatectomy 
• Radiation therapy 
• Hormonal treatment
Overview Treatment Options by Stage for Prostate Cancer 
Stage ( AJCC TNM Staging Criteria) Standard Treatment Options 
Stage I •Watchful waiting or active surveillance 
•Radical prostatectomy 
•External-beam radiation therapy (EBRT) 
•Interstitial implantation of radioisotopes 
Stage II •Watchful waiting or active surveillance 
•Radical prostatectomy 
•External-beam radiation therapy (EBRT) with or without hormonal therapy 
•Interstitial implantation of radioisotopes 
Stage III •External-beam radiation therapy (EBRT) with or without hormonal therapy 
•Hormonal manipulations (orchiectomy or luteinizing hormone-releasing hormone [LH-RH] agonist) 
•Radical prostatectomy with or without EBRT 
•Watchful waiting or active surveillance 
Stage IV •Hormonal manipulations 
•Bisphosphonates 
•External-beam radiation therapy (EBRT) with or without hormonal therapy 
•Palliative radiation therapy 
•Palliative surgery with transurethral resection of the prostate (TURP) 
•Watchful waiting or active surveillance 
Recurrent •Chemotherapy for hormonal management of prostate cancer 
•Immunotherapy
Indications for RT 
T N0 N1 M1 PSA GS 
SURVELLI 
ANCE SURGERY Radical RT 
Radical 
Brachytherapy HT 
T1a + <10 <6 YES RP+ PLND RT BRACY 
T1b + <10 <6 YES 
RP+ PLND 
(<2% +ve nodes) RT BRACY 
T1c + <10 <6 YES 
RP+ PLND 
(>2% +ve nodes) RT BRACY 
T2a + RT + ADT 
T2b + RT + ADT 
T2c + 
10 
to 
20 7 YES RP+ PLND 
RT + ADT 
+ BRACHY BOOST BRACY Y 
T3a + >20 
8 to 
10 RP+ PLND RT + ADT BRACHY BOOST Y 
T3b + RT + ADT BRACHY BOOST Y 
T4 + RT + ADT BRACHY BOOST ADT 
Any T + RT + ADT Y 
Any T / N + RT ADT
Radiation Therapy : Basics
Radiotherapy
• Radiation therapy is the art of using ionising 
radiation to destroy malignant tumours while 
being able to minimise damage to normal 
tissue.
Introduction 
• Basics of Radiation Therapy 
– Ionizing Radiation – X / γ Rays 
– Interaction of Radiation with matter 
Transmission Attenuation 
Scatter Absorption 
Rad / Gray / cGy
Cancer Cell & Ionizing Radiation 
• Cancer cell multiply faster than normal cell 
• DNA is primary target 
• Double Strand breaks 
>>> Reproductive Cell Death
RT is a Double Edge Sword
↑ RT Dose ↓ RT Dose 
↑ T – Control ↓ T – Control 
↑ Normal Tissue 
Toxicitites 
↓ Normal Tissue 
Toxicitites
EQUIPMENTS
Radiation Equipments 
Teletherapy 
• Telecobalt 
• Linear Accelerator 
– Simple Teletherapy 
– SRS/SRT 
– 2D 
– 3DCRT 
– IMRT 
– IGRT 
– Rapid Arc 
– FFF 
– SBRT 
– 4DRT – Target tracking 
– Tomotherapy 
– Cyber Knife 
• Gamma Knife 
Brachytherapy 
– Intracavitory 
– Interstitial 
– Mould 
• Pre Loaded / After 
loading 
• Manual / Remote 
• LDR / HDR 
• Permanent Implants
Linear Accelerator 
• 3DCRT > 1998+ 
• IMRT > 2000+
Linear Accelerator : 3DCRT / IMRT
Tomotherapy - 2003
Synchrony™ 
camera 
Cyber Knife – 2003+ 
Treatment couch 
Linear 
accelerator 
Targeting System 
Manipulator 
Image 
detectors 
X-ray sources 
Robotic Delivery System
IGRT - 2005
True beam - All in One FFF SBRT / 4DRT 
–
True Beam - 2010
Proton Beam therapy 2012
Brachytherapy 
• LDR - Iridium wires – Manual Interstitial <Phased 
out> 
• HDR – Iridium / Cobalt 
• Permanent Interstitial Implant – Iodine seeds
125 I Seed Implant
HDR - Brachytherapy
RT Planning Process
Radiation Therapy 
Prostate Cancer : 
• Disease Characterization : 
• Clinical - KPS/Co-existing Morbidities/TRUS/ CT/MR 
• TNM/PSA/GS 
– Primary 
– Primary + Regional nodes 
• + ADT 
PSA (ng/ml) +VE PELVIC NODE YEILD 
4-20 < 12% 
>20 > 10% 
> 25 30-35% 
> 50 + high GS 62%
Radiation Therapy : Intent Defn 
• Radical RT 
– RT alone: 
– Conventional (7-8 weeks) < 
– Hyperfractionation (5-6 weeks) 
– Hypofractionation (1-2 Gap 1-2 weeks) < CK / SRS / SBRT 
– Photons alone 
– Recent adv - Photons + Particle (Protons) 
– Protons alone 
– RT + Hormon therapy (HT) 
– RT + Radiation Protectors (Amifostine) 
– Teletherapy + Brachytherapy Boost 
– Brachytherapy alone 
• Brachy type: Volume implants 
– Temporary Implant – HDR 
– Permanaent Implant – I 125 
• Post Operative RT (5-7 weeks) 
• Salvage RT / Re-irradiation 
• Palliative RT 
– Short Course (1day, 1-2 weeks) 
– Saturation Technique (1-2 weeks gap 3-4 weks)
RT Techniques 
• Teletherapy 
– 2 D 
– 3 D Conformal 
– IMRT 
– IGRT 
– Tomotherapy 
– CK SRS / SRT 
– Rapid arc 
– SBRT - FFF 
– Proton 
• Bracytherapy 
– Interstital 
• HDR – Ir - Temporary 
• 125 Iodine - Permanent
Indications for RT in Ca Prostate 
• Radical RT 
– T1, T2, T3, T4a 
• Un-resectable (Altered Fractionation HF/CB or RT + HT ) 
• elderly, frail, comorbid conditions 
• refusal for surgery 
• prohibitive morbidity due to surgery 
• Post OP RT : after Radical Prostatectomy 
– pT3/4 
– Close & +ve margin 
– Extra Capsular extension 
– Invasion to 
• Seminal vesicle 
• Extraprostatic extensions 
– Multiple nodes 
– R 1 resection 
• Pre OP PSA > 10ng/ml 
• Pre OP PSA velocity > 2ng/ml/year 
– Post RP – Recurrent disease 
– Post RP - early PSA failures
RADIOTHERAPY DOSE 
1. External : 
a. IMRT / IGRT / Rapid Arc / Protons : 
– > 7400 cGy to 7600 cGy / 6-8 wks 
– 180-200cGy / fr, 5fr/wk 
b. CK / SBRT / FFF : 5 – 20 Gy / fr, 3-5 fr 
c. Post-op.: 60-66 Gy / 6-7 wks 
d. Palliative RT: 30Gy/10f, 20Gy/5 or 4f, 7-8Gy/1f 
2. Brachytherapy : 
a. Alone : 6000 - 7000 cGy in 6 to 7 days. 
b. External + Brachytherapy 
Ext : 46-50 Gy in 4 1/2 - 5 1/2 wks. + 
Brachy : 2000-3000 cGy in 2-3 days 
HDR : 9.5Gy x 2f, as mono therapy 9.5Gy bid x 4f x 2dys 
I -125 : 0.2-0.9mCi, T1/2-17dy, 21Kev
RT Dose 
• 2D : 66Gy , 1.8-2Gy/f, 5f/wk 
• 3DCRT : 70-75Gy 
• IMRT /IGRT : 75 – 81Gy
Patient
RT Planning 
• Informed Consent : 
• Implant Fidutial - +/- (if GC is not favorable CBCT ) 
• Mould room work : Patient positioning, knee rest 
• Virtual CT Simulation 
• Contouring 
• RT planning 
• Plan evaluation and acceptance 
• QA tests
Fidutial Placement 
• TRUS Guided 
• 1 week prior to simulation
Flat Couch 
CT Simulator
Instructions for Virtual Simulation 
Mould room techniques: 
• Bowel / Bladder – post void (full – if u/s Tracking) 
• Patient Positioning : Supine (↓ P motion) / Prone 
• Thermoplastic mold – Pelvic cast - knee to mid thigh + Tattooe / 
Tegaderm 
• Knee rest 
Virtual simulation : Flat Couch 
– Patient repositioning 
– Pelvis : pubic symphysis - Laser set (mid / 2 lateral – 5cms post) – marking 
– Radio-opaque markers 
– CT Sim - 3mm 
– Scan : 20-30 cms above & 20-30 cms below the marker plane
Contouring 
• Data transfer : from CT sim to RT planning system – 
DICOM format 
• Patient registration : CT data / CT + MR Fusion data 
• Contouring : Target & Normal tissue 
– CTV – P alone / P + SV / P + SV + Pelvic Ly nodes 
– PTV – CTV + Margin 
• Cobalt / 2D / 3DCRT - 2cms 
• IMRT – 1cms (in all directions except rectal interface – 0.6cms) 
• IGRT – 0.6 cms all round 
• CK/SBRT – 0.3 cms all round 
– Prostatic apex definition – urethrogram / MRI
On the machine 
• Machine QA for the Planned treatment 
• Patient positioning and verification 
• Portal Imaging & setup verification + CBCT 
• Treatment plan execution 
• Daily QA 
• Daily Portal imaging /MV – KV / CBCT / 3D CBCT 
• Monitoring of Acute radiation reaction and 
supportive cares
Beam selection and planning 
• 2 D : 
– AP: PA 
– AP : PA : RT Lat : Lt Lat 
• 3 DCRT : 6 Coplanar ( 2 – lat, 2 Ant & 2 Post Obliques ) 
– Plan evaluation : 
• Dose distribution (isocentre) – Transverse / Coronal / Sagittal 
• DVH 
• Beam weighing – 2 lat – half the dose 
• Uniform dose in PTV 
• Elimination of hot spot from rectum 
• Plan normalization : 
• Prescription iso-dose – 100% coverage of PTV 
• PTV Hot spot < 6-9% 
• Rectal volume in PTV 75.6G < 30% 
• Femur < 68Gy (90%) 
• Large bowel < 60Gy (79%) 
• Small bowel < 50 gy (66%)
2D plan – Orthogonal X Ray simulation
• 3DCRT MLC 
based 
conformal field
Evolution of conformality 
2D RT 3DCRT 
IMRT Rapid Arc
TOMOTHERAPY : 78Gy
AMS CONFIDENTIAL 
Cyber knife
Rapid Arc
Patient on Treatment
Protons
Proton Therapy vs. IMRT 
 Dosimetric study: 
 10 IMRT vs.10 proton 
beam to 78 Gy 
 Mean rectal dose-volume 
histograms 
Vargas et al. IJROBP 2007
Proton Therapy vs. IMRT
Brachytherapy
Interstitial 
Brachytherapy
Prostate Brachytherapy
Prostate Brachytherapy 
Iodine 125 
t ½ = 60 days 
Gamma emitter 
Energy 35 kV
During RT
Target Motion ITV Management 
• Daily localization IGRT techniques to account 
for interfraction motion: 
– intraprostatic fiducial markers with daily imaging 
– transabdominal US 
– daily in-room CT imaging 
– endorectal balloon immobilization 
• All of these methods employ daily imaging of 
the prostate in the treatment room.
Target Tracking 
• During RT 
– Celing mounted Cross fired X-Ray / Fluro eg.CK, X Tack 
– 
• Before RT 
– Orthogonal KV / MV Portal imaging – best with fidutial 
– CBCT / Onrail CT – suitable for patients without 
fidutials
Ceiling mounted Cross fired X Rays
Motion Management 
reference (simulation film) online (port film) co-registered 
(right) 
In this technique, the isocenter is shifted until the bony contours (setup error) or the implanted markers 
are in agreement (total error).
Motion Management 
 Cone beam computerized 
tomography (CBCT) allows volumetric 
visualization of the prostate and 
adjacent organs. 
– Daily online correction allows for 
PTV margins: 
• 4 mm in all directions and 3 
mm posterior (Pawlowski, Red 
Journal 2010) 
• 5 mm all around and 3 mm 
posterior (Hammoud, Red 
Journal 2008) 
2 stages of image registration: Top: pelvic bone region of interest 
Bottom: prostate/sv represented by masked area.
Motion Management 
• Intrafraction Motion 
– Changes in position while the treatment beam is on 
(“second by second”) 
– Mostly from peristalsis/gas, pelvic floor movement, 
respiration coughing, etc. 
– Techniques to account for intrafraction motion: 
• RGRT (radiofrequency-guided RT techniques) 
• Rectal balloon 
• Bowel prep (anti-gas tablets and daily bm) 
• Consistent Bladder filling
Motion management 
 Endorectal balloon 
– Used for prostate 
immobilization/fixation 
– Ensures reproducibility of 
rectal filling and spares 
posterior rectum 
Teh, Red Journal 2001 
78 Gy IMRT plans without (left) and with 
balloon (right) 
Contours: rectal wall (green), anal wall 
(purple) and PTV (blue).
Treatment results
PSA relapse free survival rate (%) 
~ EBRT RP BRACHY 
5 YRS 79 81 98 
8 YRS 70 72 92
androgen suppression or androgen 
deprivation therapy.
most commonly used hormone 
therapies 
• Orchiectomy 
Medical Castration - reversible 
• luteinizing hormone-releasing hormone (LHRH) agonists – 
synthetic proteins - similar to LHRH and bind to the 
LHRH receptor in the pitutary gland- causes the pituitary gland 
to stop producing luteinizing hormone, which prevents 
testosterone from being produced- leuprolide, goserelin, 
and buserelin 
• LHRH antagonists - act by preventing LHRH from binding to 
its receptors in the pitutary gland
Toxicities 
Impotence rates 
• Brachy alone – 24% 
• Brachy + EBRT – 40% 
• EBRT alone – 45% 
• Nerve sparing RP – 66% 
• RP – 75% 
• Cryosurgery – 87% 
Urinary control 
• RP – 35% 
• RT – 97%
Summary and 
Conclusion
Advances in newer radiation 
technologies 
• Enhanced Normal Tissue Sparing 
• Reduces side effects 
• Dose Escalation has Improved Cure Rate 
• Higher Dose per Fraction reduces hospital visits 
• Reduce Number of fractions 
• Reduce Treatment Duration
Thank you

More Related Content

What's hot

Radiotherapy in ca esophagus
Radiotherapy in ca esophagusRadiotherapy in ca esophagus
Radiotherapy in ca esophagus
Isha Jaiswal
 
Radiotherapy in carcinoma rectum
Radiotherapy in carcinoma rectumRadiotherapy in carcinoma rectum
Radiotherapy in carcinoma rectum
Sagar Raut
 
Quantec dr. upasna saxena (2)
Quantec   dr. upasna saxena (2)Quantec   dr. upasna saxena (2)
Quantec dr. upasna saxena (2)
Upasna Saxena
 
SBRT Contouring Guidelines
SBRT  Contouring  GuidelinesSBRT  Contouring  Guidelines
SBRT Contouring Guidelines
Dr Rushi Panchal
 
IMRT in Prostate Cancer
IMRT in Prostate CancerIMRT in Prostate Cancer
IMRT in Prostate Cancer
Dr.Ram Madhavan
 
brachytherapy in carcinoma prostate
brachytherapy in carcinoma prostatebrachytherapy in carcinoma prostate
brachytherapy in carcinoma prostate
Sailendra Parida
 
image guided brachytherapy carcinoma cervix
image guided brachytherapy carcinoma cerviximage guided brachytherapy carcinoma cervix
image guided brachytherapy carcinoma cervix
Isha Jaiswal
 
TARGET DELINEATION OF CANCER ESOPHAGUS
TARGET DELINEATION OF CANCER ESOPHAGUSTARGET DELINEATION OF CANCER ESOPHAGUS
TARGET DELINEATION OF CANCER ESOPHAGUS
Kanhu Charan
 
Radiotherapy for bladder cancers
Radiotherapy for bladder cancersRadiotherapy for bladder cancers
Radiotherapy for bladder cancersAshutosh Mukherji
 
Radiotherapy techniques for Breast Cancer
Radiotherapy techniques for Breast CancerRadiotherapy techniques for Breast Cancer
Radiotherapy techniques for Breast Cancer
Animesh Agrawal
 
BOOK ON REIRRADIATION
BOOK ON REIRRADIATIONBOOK ON REIRRADIATION
BOOK ON REIRRADIATION
Kanhu Charan
 
Radiotherapy lymphoma
Radiotherapy lymphoma Radiotherapy lymphoma
Radiotherapy lymphoma
vrinda singla
 
Prostate ca
Prostate caProstate ca
radiation therapy in ca breast
radiation therapy in ca breast   radiation therapy in ca breast
radiation therapy in ca breast
Isha Jaiswal
 
Srs and sbrt 2 dr.kiran
Srs and sbrt 2 dr.kiranSrs and sbrt 2 dr.kiran
Srs and sbrt 2 dr.kiran
Kiran Ramakrishna
 
Role of radiation in carcinoma rectum and colon
Role of radiation in carcinoma rectum and colon Role of radiation in carcinoma rectum and colon
Role of radiation in carcinoma rectum and colon Bharti Devnani
 
Radiation for the Treatment of Bladder Cancer
Radiation for the Treatment of Bladder CancerRadiation for the Treatment of Bladder Cancer
Radiation for the Treatment of Bladder Cancer
Robert J Miller MD
 
ICRU 89 summary & beyond converted
ICRU 89 summary & beyond convertedICRU 89 summary & beyond converted
ICRU 89 summary & beyond converted
Dr. Abhishek Basu
 
Delineation of dysphagia aspiration related structures
Delineation of dysphagia aspiration related structuresDelineation of dysphagia aspiration related structures
Delineation of dysphagia aspiration related structures
Rajesh Balakrishnan
 
HYPOFRACTIONATION IN RADIOTHERAPY
HYPOFRACTIONATION IN RADIOTHERAPYHYPOFRACTIONATION IN RADIOTHERAPY
HYPOFRACTIONATION IN RADIOTHERAPY
Rejil Rajan
 

What's hot (20)

Radiotherapy in ca esophagus
Radiotherapy in ca esophagusRadiotherapy in ca esophagus
Radiotherapy in ca esophagus
 
Radiotherapy in carcinoma rectum
Radiotherapy in carcinoma rectumRadiotherapy in carcinoma rectum
Radiotherapy in carcinoma rectum
 
Quantec dr. upasna saxena (2)
Quantec   dr. upasna saxena (2)Quantec   dr. upasna saxena (2)
Quantec dr. upasna saxena (2)
 
SBRT Contouring Guidelines
SBRT  Contouring  GuidelinesSBRT  Contouring  Guidelines
SBRT Contouring Guidelines
 
IMRT in Prostate Cancer
IMRT in Prostate CancerIMRT in Prostate Cancer
IMRT in Prostate Cancer
 
brachytherapy in carcinoma prostate
brachytherapy in carcinoma prostatebrachytherapy in carcinoma prostate
brachytherapy in carcinoma prostate
 
image guided brachytherapy carcinoma cervix
image guided brachytherapy carcinoma cerviximage guided brachytherapy carcinoma cervix
image guided brachytherapy carcinoma cervix
 
TARGET DELINEATION OF CANCER ESOPHAGUS
TARGET DELINEATION OF CANCER ESOPHAGUSTARGET DELINEATION OF CANCER ESOPHAGUS
TARGET DELINEATION OF CANCER ESOPHAGUS
 
Radiotherapy for bladder cancers
Radiotherapy for bladder cancersRadiotherapy for bladder cancers
Radiotherapy for bladder cancers
 
Radiotherapy techniques for Breast Cancer
Radiotherapy techniques for Breast CancerRadiotherapy techniques for Breast Cancer
Radiotherapy techniques for Breast Cancer
 
BOOK ON REIRRADIATION
BOOK ON REIRRADIATIONBOOK ON REIRRADIATION
BOOK ON REIRRADIATION
 
Radiotherapy lymphoma
Radiotherapy lymphoma Radiotherapy lymphoma
Radiotherapy lymphoma
 
Prostate ca
Prostate caProstate ca
Prostate ca
 
radiation therapy in ca breast
radiation therapy in ca breast   radiation therapy in ca breast
radiation therapy in ca breast
 
Srs and sbrt 2 dr.kiran
Srs and sbrt 2 dr.kiranSrs and sbrt 2 dr.kiran
Srs and sbrt 2 dr.kiran
 
Role of radiation in carcinoma rectum and colon
Role of radiation in carcinoma rectum and colon Role of radiation in carcinoma rectum and colon
Role of radiation in carcinoma rectum and colon
 
Radiation for the Treatment of Bladder Cancer
Radiation for the Treatment of Bladder CancerRadiation for the Treatment of Bladder Cancer
Radiation for the Treatment of Bladder Cancer
 
ICRU 89 summary & beyond converted
ICRU 89 summary & beyond convertedICRU 89 summary & beyond converted
ICRU 89 summary & beyond converted
 
Delineation of dysphagia aspiration related structures
Delineation of dysphagia aspiration related structuresDelineation of dysphagia aspiration related structures
Delineation of dysphagia aspiration related structures
 
HYPOFRACTIONATION IN RADIOTHERAPY
HYPOFRACTIONATION IN RADIOTHERAPYHYPOFRACTIONATION IN RADIOTHERAPY
HYPOFRACTIONATION IN RADIOTHERAPY
 

Viewers also liked

Future Developments In Radiation Therapy For Prostate Cancer
Future Developments In Radiation Therapy For Prostate CancerFuture Developments In Radiation Therapy For Prostate Cancer
Future Developments In Radiation Therapy For Prostate Cancerfondas vakalis
 
ECCLU 2011 - T. Wiegel - Prostate cancer: Managing of pelvic nodes - Radiatio...
ECCLU 2011 - T. Wiegel - Prostate cancer: Managing of pelvic nodes - Radiatio...ECCLU 2011 - T. Wiegel - Prostate cancer: Managing of pelvic nodes - Radiatio...
ECCLU 2011 - T. Wiegel - Prostate cancer: Managing of pelvic nodes - Radiatio...European School of Oncology
 
Prostate cancer radiotherapy
Prostate cancer radiotherapyProstate cancer radiotherapy
Prostate cancer radiotherapy
mohamed alhefny
 
Igrt For Prostate Cancer
Igrt For Prostate CancerIgrt For Prostate Cancer
Igrt For Prostate CancerSapna Nangia
 
Radiation Therapy - Prostate Cancer
Radiation Therapy - Prostate CancerRadiation Therapy - Prostate Cancer
Radiation Therapy - Prostate CancerBiancz Noveno
 
Prostate Cancer and the Role of PostOp Radiation
Prostate Cancer and the Role of PostOp RadiationProstate Cancer and the Role of PostOp Radiation
Prostate Cancer and the Role of PostOp Radiation
Robert J Miller MD
 
Brachytherapy: Prostate Cancer
Brachytherapy: Prostate CancerBrachytherapy: Prostate Cancer
Brachytherapy: Prostate Cancer
Loghin Dumitru
 
Prostate Cancer
Prostate CancerProstate Cancer
Prostate Cancer
Robert J Miller MD
 
Metastatic prostate cancer
Metastatic prostate cancerMetastatic prostate cancer
Metastatic prostate cancer
prashantkumbhaj
 
ECCLU 2011 - S. Supiot - Locally advanced prostate cancer: Multimodality trea...
ECCLU 2011 - S. Supiot - Locally advanced prostate cancer: Multimodality trea...ECCLU 2011 - S. Supiot - Locally advanced prostate cancer: Multimodality trea...
ECCLU 2011 - S. Supiot - Locally advanced prostate cancer: Multimodality trea...European School of Oncology
 
MANAGEMENT OF PROSTATE CA
MANAGEMENT OF PROSTATE CAMANAGEMENT OF PROSTATE CA
MANAGEMENT OF PROSTATE CA
radiation oncology
 
Radical Prostate Radiotherapy
Radical Prostate RadiotherapyRadical Prostate Radiotherapy
Radical Prostate Radiotherapy
Catherine Holborn
 
Prostate Cancer
Prostate CancerProstate Cancer
Prostate Cancer
Abdulaziz Alanzi
 
physics and clinical aspects of interstitial brachytherapy
physics and clinical aspects of interstitial brachytherapyphysics and clinical aspects of interstitial brachytherapy
physics and clinical aspects of interstitial brachytherapyVIMOJ JANARDANAN NAIR
 
Metastatic prostate cancer.. a guide for treatment choice
Metastatic prostate cancer.. a guide for treatment choiceMetastatic prostate cancer.. a guide for treatment choice
Metastatic prostate cancer.. a guide for treatment choice
Osama Elzaafarany, MD.
 
Prostate Cancer G Bauman
Prostate Cancer G BaumanProstate Cancer G Bauman
Prostate Cancer G Baumanfondas vakalis
 
CARCINOMA PROSTATE- Dr Manoj Kumar B, PGI
CARCINOMA PROSTATE- Dr Manoj Kumar B, PGICARCINOMA PROSTATE- Dr Manoj Kumar B, PGI
CARCINOMA PROSTATE- Dr Manoj Kumar B, PGIPGIMER, AIIMS
 

Viewers also liked (20)

Future Developments In Radiation Therapy For Prostate Cancer
Future Developments In Radiation Therapy For Prostate CancerFuture Developments In Radiation Therapy For Prostate Cancer
Future Developments In Radiation Therapy For Prostate Cancer
 
ECCLU 2011 - T. Wiegel - Prostate cancer: Managing of pelvic nodes - Radiatio...
ECCLU 2011 - T. Wiegel - Prostate cancer: Managing of pelvic nodes - Radiatio...ECCLU 2011 - T. Wiegel - Prostate cancer: Managing of pelvic nodes - Radiatio...
ECCLU 2011 - T. Wiegel - Prostate cancer: Managing of pelvic nodes - Radiatio...
 
Prostate cancer radiotherapy
Prostate cancer radiotherapyProstate cancer radiotherapy
Prostate cancer radiotherapy
 
Igrt For Prostate Cancer
Igrt For Prostate CancerIgrt For Prostate Cancer
Igrt For Prostate Cancer
 
Radiation Therapy - Prostate Cancer
Radiation Therapy - Prostate CancerRadiation Therapy - Prostate Cancer
Radiation Therapy - Prostate Cancer
 
Prostate Cancer and the Role of PostOp Radiation
Prostate Cancer and the Role of PostOp RadiationProstate Cancer and the Role of PostOp Radiation
Prostate Cancer and the Role of PostOp Radiation
 
Brachytherapy: Prostate Cancer
Brachytherapy: Prostate CancerBrachytherapy: Prostate Cancer
Brachytherapy: Prostate Cancer
 
Prostate Cancer
Prostate CancerProstate Cancer
Prostate Cancer
 
Metastatic prostate cancer
Metastatic prostate cancerMetastatic prostate cancer
Metastatic prostate cancer
 
D de Jong, Prostate cancer brachytherapy
D de Jong, Prostate cancer brachytherapyD de Jong, Prostate cancer brachytherapy
D de Jong, Prostate cancer brachytherapy
 
ECCLU 2011 - S. Supiot - Locally advanced prostate cancer: Multimodality trea...
ECCLU 2011 - S. Supiot - Locally advanced prostate cancer: Multimodality trea...ECCLU 2011 - S. Supiot - Locally advanced prostate cancer: Multimodality trea...
ECCLU 2011 - S. Supiot - Locally advanced prostate cancer: Multimodality trea...
 
MANAGEMENT OF PROSTATE CA
MANAGEMENT OF PROSTATE CAMANAGEMENT OF PROSTATE CA
MANAGEMENT OF PROSTATE CA
 
Radical Prostate Radiotherapy
Radical Prostate RadiotherapyRadical Prostate Radiotherapy
Radical Prostate Radiotherapy
 
Prostate Cancer
Prostate CancerProstate Cancer
Prostate Cancer
 
physics and clinical aspects of interstitial brachytherapy
physics and clinical aspects of interstitial brachytherapyphysics and clinical aspects of interstitial brachytherapy
physics and clinical aspects of interstitial brachytherapy
 
Metastatic prostate cancer.. a guide for treatment choice
Metastatic prostate cancer.. a guide for treatment choiceMetastatic prostate cancer.. a guide for treatment choice
Metastatic prostate cancer.. a guide for treatment choice
 
Prostate Cancer G Bauman
Prostate Cancer G BaumanProstate Cancer G Bauman
Prostate Cancer G Bauman
 
Radiation therapy of oral cancers
Radiation therapy of oral cancersRadiation therapy of oral cancers
Radiation therapy of oral cancers
 
Brachytherapy
BrachytherapyBrachytherapy
Brachytherapy
 
CARCINOMA PROSTATE- Dr Manoj Kumar B, PGI
CARCINOMA PROSTATE- Dr Manoj Kumar B, PGICARCINOMA PROSTATE- Dr Manoj Kumar B, PGI
CARCINOMA PROSTATE- Dr Manoj Kumar B, PGI
 

Similar to Radiation therapy in prostate cancer

Imaging prostate cancer astellas
Imaging prostate cancer astellasImaging prostate cancer astellas
Imaging prostate cancer astellas
Mohamed Abdulla
 
Prostate cancer
Prostate cancer Prostate cancer
Prostate cancer
Vinay Kumar
 
5 Basics of Prostate Cancer.pptx
5 Basics of Prostate Cancer.pptx5 Basics of Prostate Cancer.pptx
5 Basics of Prostate Cancer.pptx
Dr Ankur Shah
 
Overview of Carcinoma Prostate and Genetics
Overview of Carcinoma Prostate and GeneticsOverview of Carcinoma Prostate and Genetics
Overview of Carcinoma Prostate and Genetics
DrAyush Garg
 
Nasopharyngeal cancer
Nasopharyngeal cancer Nasopharyngeal cancer
Nasopharyngeal cancer
Ajay Manickam
 
Post Operative RT in Carcinoma prostate
Post Operative RT in Carcinoma prostatePost Operative RT in Carcinoma prostate
Post Operative RT in Carcinoma prostate
Sreekanth Nallam
 
Renal cell carcinoma
Renal cell carcinomaRenal cell carcinoma
Renal cell carcinoma
Robal Lacoul
 
RENAL CELL CARCINOMA.pptx
RENAL CELL CARCINOMA.pptxRENAL CELL CARCINOMA.pptx
RENAL CELL CARCINOMA.pptx
Dr Monica P
 
Renal Cell Carcinoma.pptx
Renal Cell Carcinoma.pptxRenal Cell Carcinoma.pptx
Renal Cell Carcinoma.pptx
Daniroxx
 
THYROID MALIGNANCIES.pptx
THYROID MALIGNANCIES.pptxTHYROID MALIGNANCIES.pptx
THYROID MALIGNANCIES.pptx
masoom parwez
 
Thyroid malignancies
Thyroid malignanciesThyroid malignancies
Thyroid malignancies
Shashank Bansal
 
Prostate presentation.Ca prostate etiology staging
Prostate presentation.Ca prostate etiology stagingProstate presentation.Ca prostate etiology staging
Prostate presentation.Ca prostate etiology staging
OSBORNMIKE
 
Oncoimaging: prostate cancer
Oncoimaging: prostate cancerOncoimaging: prostate cancer
Oncoimaging: prostate cancer
Thorsang Chayovan
 
Intern talk prostate and testis cancer 2015
Intern talk prostate and testis cancer 2015Intern talk prostate and testis cancer 2015
Intern talk prostate and testis cancer 2015
katejohnpunag
 
spinal metastasis
spinal metastasisspinal metastasis
spinal metastasis
DheerajJonnalagadda1
 
Prostate
ProstateProstate
Prostate
Parneet Singh
 
Haematuria & urinary tract malignancy
Haematuria & urinary tract malignancyHaematuria & urinary tract malignancy
Haematuria & urinary tract malignancy
Chea Chan Hooi
 
Carcinoma of prostate
Carcinoma of prostateCarcinoma of prostate
Carcinoma of prostate
Ashwini Maurya
 
THYROID CANCER.pptx
THYROID CANCER.pptxTHYROID CANCER.pptx
THYROID CANCER.pptx
NurAmaleezaAbdulMana
 

Similar to Radiation therapy in prostate cancer (20)

Imaging prostate cancer astellas
Imaging prostate cancer astellasImaging prostate cancer astellas
Imaging prostate cancer astellas
 
Prostate cancer
Prostate cancer Prostate cancer
Prostate cancer
 
5 Basics of Prostate Cancer.pptx
5 Basics of Prostate Cancer.pptx5 Basics of Prostate Cancer.pptx
5 Basics of Prostate Cancer.pptx
 
Overview of Carcinoma Prostate and Genetics
Overview of Carcinoma Prostate and GeneticsOverview of Carcinoma Prostate and Genetics
Overview of Carcinoma Prostate and Genetics
 
Nasopharyngeal cancer
Nasopharyngeal cancer Nasopharyngeal cancer
Nasopharyngeal cancer
 
Post Operative RT in Carcinoma prostate
Post Operative RT in Carcinoma prostatePost Operative RT in Carcinoma prostate
Post Operative RT in Carcinoma prostate
 
Renal cell carcinoma
Renal cell carcinomaRenal cell carcinoma
Renal cell carcinoma
 
RENAL CELL CARCINOMA.pptx
RENAL CELL CARCINOMA.pptxRENAL CELL CARCINOMA.pptx
RENAL CELL CARCINOMA.pptx
 
Renal Cell Carcinoma.pptx
Renal Cell Carcinoma.pptxRenal Cell Carcinoma.pptx
Renal Cell Carcinoma.pptx
 
THYROID MALIGNANCIES.pptx
THYROID MALIGNANCIES.pptxTHYROID MALIGNANCIES.pptx
THYROID MALIGNANCIES.pptx
 
Thyroid malignancies
Thyroid malignanciesThyroid malignancies
Thyroid malignancies
 
Prostate presentation.Ca prostate etiology staging
Prostate presentation.Ca prostate etiology stagingProstate presentation.Ca prostate etiology staging
Prostate presentation.Ca prostate etiology staging
 
Oncoimaging: prostate cancer
Oncoimaging: prostate cancerOncoimaging: prostate cancer
Oncoimaging: prostate cancer
 
Intern talk prostate and testis cancer 2015
Intern talk prostate and testis cancer 2015Intern talk prostate and testis cancer 2015
Intern talk prostate and testis cancer 2015
 
Carcinoma prostate
Carcinoma prostateCarcinoma prostate
Carcinoma prostate
 
spinal metastasis
spinal metastasisspinal metastasis
spinal metastasis
 
Prostate
ProstateProstate
Prostate
 
Haematuria & urinary tract malignancy
Haematuria & urinary tract malignancyHaematuria & urinary tract malignancy
Haematuria & urinary tract malignancy
 
Carcinoma of prostate
Carcinoma of prostateCarcinoma of prostate
Carcinoma of prostate
 
THYROID CANCER.pptx
THYROID CANCER.pptxTHYROID CANCER.pptx
THYROID CANCER.pptx
 

More from Kidwai Memorial Institute of Oncology, Bangalore

AI & Recent Advances in Radiation Oncology 2024
AI & Recent Advances in Radiation Oncology 2024AI & Recent Advances in Radiation Oncology 2024
AI & Recent Advances in Radiation Oncology 2024
Kidwai Memorial Institute of Oncology, Bangalore
 
Road map to eliminate Cervical Cancer in the Indian subcontinent 2023 Dr V ...
Road map to eliminate  Cervical Cancer in the Indian subcontinent  2023 Dr V ...Road map to eliminate  Cervical Cancer in the Indian subcontinent  2023 Dr V ...
Road map to eliminate Cervical Cancer in the Indian subcontinent 2023 Dr V ...
Kidwai Memorial Institute of Oncology, Bangalore
 
Permanent implant Brachytherapy
Permanent implant BrachytherapyPermanent implant Brachytherapy
Permanent implant Brachytherapy
Kidwai Memorial Institute of Oncology, Bangalore
 
Research in India Bangalore Tech Expo 2018
Research in India Bangalore Tech Expo 2018Research in India Bangalore Tech Expo 2018
Research in India Bangalore Tech Expo 2018
Kidwai Memorial Institute of Oncology, Bangalore
 
Motion management in Radiation Oncology - 2020
Motion management in Radiation Oncology - 2020Motion management in Radiation Oncology - 2020
Motion management in Radiation Oncology - 2020
Kidwai Memorial Institute of Oncology, Bangalore
 
Nutrition in cancer patients dr lokesh 2021 introduction
Nutrition in cancer patients dr lokesh 2021 introductionNutrition in cancer patients dr lokesh 2021 introduction
Nutrition in cancer patients dr lokesh 2021 introduction
Kidwai Memorial Institute of Oncology, Bangalore
 
Future Technological needs in Oncology
Future Technological needs in Oncology Future Technological needs in Oncology
Future Technological needs in Oncology
Kidwai Memorial Institute of Oncology, Bangalore
 
Radiation Therapy in Colon and Rectal Cancer - Multidisciplinary seminar 1993
Radiation Therapy in Colon and Rectal Cancer  - Multidisciplinary seminar 1993Radiation Therapy in Colon and Rectal Cancer  - Multidisciplinary seminar 1993
Radiation Therapy in Colon and Rectal Cancer - Multidisciplinary seminar 1993
Kidwai Memorial Institute of Oncology, Bangalore
 
Radiation Therapy in Oral Cancer 2018
Radiation Therapy in Oral Cancer 2018Radiation Therapy in Oral Cancer 2018
Radiation Therapy in Oral Cancer 2018
Kidwai Memorial Institute of Oncology, Bangalore
 
Radiotherapy in Cancer Oesophagus 1993
Radiotherapy in Cancer Oesophagus 1993Radiotherapy in Cancer Oesophagus 1993
Radiotherapy in Cancer Oesophagus 1993
Kidwai Memorial Institute of Oncology, Bangalore
 
Radiotherapy in Carcinoma of the Urinary Bladder 1993
Radiotherapy in Carcinoma of the Urinary Bladder 1993Radiotherapy in Carcinoma of the Urinary Bladder 1993
Radiotherapy in Carcinoma of the Urinary Bladder 1993
Kidwai Memorial Institute of Oncology, Bangalore
 
Breast Cancer Radiation Therapy: RT Plan evaluation & Recent Advances - 4DCT ...
Breast Cancer Radiation Therapy: RT Plan evaluation & Recent Advances - 4DCT ...Breast Cancer Radiation Therapy: RT Plan evaluation & Recent Advances - 4DCT ...
Breast Cancer Radiation Therapy: RT Plan evaluation & Recent Advances - 4DCT ...
Kidwai Memorial Institute of Oncology, Bangalore
 
Radiotherapy and Skin reaction
Radiotherapy and Skin reaction Radiotherapy and Skin reaction
Radiotherapy and Skin reaction
Kidwai Memorial Institute of Oncology, Bangalore
 
Radiotherapy : Past Present Future KMIO 2015
Radiotherapy :  Past Present Future  KMIO 2015Radiotherapy :  Past Present Future  KMIO 2015
Radiotherapy : Past Present Future KMIO 2015
Kidwai Memorial Institute of Oncology, Bangalore
 
Radiation therapy in Cancer Oesophagus
Radiation therapy in Cancer Oesophagus Radiation therapy in Cancer Oesophagus
Radiation therapy in Cancer Oesophagus
Kidwai Memorial Institute of Oncology, Bangalore
 
EGFR in cervical cancer
EGFR in cervical cancerEGFR in cervical cancer
ABRAXANE in Radiation Therapy
ABRAXANE in Radiation TherapyABRAXANE in Radiation Therapy
IMPROVISED RADIOTHERAPY TECHNIQUES IN TELE COBALT WITHOUT MLC
IMPROVISED RADIOTHERAPY TECHNIQUES IN TELE COBALT WITHOUT MLCIMPROVISED RADIOTHERAPY TECHNIQUES IN TELE COBALT WITHOUT MLC
IMPROVISED RADIOTHERAPY TECHNIQUES IN TELE COBALT WITHOUT MLC
Kidwai Memorial Institute of Oncology, Bangalore
 

More from Kidwai Memorial Institute of Oncology, Bangalore (20)

AI & Recent Advances in Radiation Oncology 2024
AI & Recent Advances in Radiation Oncology 2024AI & Recent Advances in Radiation Oncology 2024
AI & Recent Advances in Radiation Oncology 2024
 
Road map to eliminate Cervical Cancer in the Indian subcontinent 2023 Dr V ...
Road map to eliminate  Cervical Cancer in the Indian subcontinent  2023 Dr V ...Road map to eliminate  Cervical Cancer in the Indian subcontinent  2023 Dr V ...
Road map to eliminate Cervical Cancer in the Indian subcontinent 2023 Dr V ...
 
Permanent implant Brachytherapy
Permanent implant BrachytherapyPermanent implant Brachytherapy
Permanent implant Brachytherapy
 
Research in India Bangalore Tech Expo 2018
Research in India Bangalore Tech Expo 2018Research in India Bangalore Tech Expo 2018
Research in India Bangalore Tech Expo 2018
 
Motion management in Radiation Oncology - 2020
Motion management in Radiation Oncology - 2020Motion management in Radiation Oncology - 2020
Motion management in Radiation Oncology - 2020
 
Nutrition in cancer patients dr lokesh 2021 introduction
Nutrition in cancer patients dr lokesh 2021 introductionNutrition in cancer patients dr lokesh 2021 introduction
Nutrition in cancer patients dr lokesh 2021 introduction
 
Future Technological needs in Oncology
Future Technological needs in Oncology Future Technological needs in Oncology
Future Technological needs in Oncology
 
Radiation Therapy in Colon and Rectal Cancer - Multidisciplinary seminar 1993
Radiation Therapy in Colon and Rectal Cancer  - Multidisciplinary seminar 1993Radiation Therapy in Colon and Rectal Cancer  - Multidisciplinary seminar 1993
Radiation Therapy in Colon and Rectal Cancer - Multidisciplinary seminar 1993
 
Radiation Therapy in Oral Cancer 2018
Radiation Therapy in Oral Cancer 2018Radiation Therapy in Oral Cancer 2018
Radiation Therapy in Oral Cancer 2018
 
Radiotherapy in Cancer Oesophagus 1993
Radiotherapy in Cancer Oesophagus 1993Radiotherapy in Cancer Oesophagus 1993
Radiotherapy in Cancer Oesophagus 1993
 
Radiotherapy in Carcinoma of the Urinary Bladder 1993
Radiotherapy in Carcinoma of the Urinary Bladder 1993Radiotherapy in Carcinoma of the Urinary Bladder 1993
Radiotherapy in Carcinoma of the Urinary Bladder 1993
 
Breast Cancer Radiation Therapy: RT Plan evaluation & Recent Advances - 4DCT ...
Breast Cancer Radiation Therapy: RT Plan evaluation & Recent Advances - 4DCT ...Breast Cancer Radiation Therapy: RT Plan evaluation & Recent Advances - 4DCT ...
Breast Cancer Radiation Therapy: RT Plan evaluation & Recent Advances - 4DCT ...
 
Radiotherapy and Skin reaction
Radiotherapy and Skin reaction Radiotherapy and Skin reaction
Radiotherapy and Skin reaction
 
Radiotherapy : Past Present Future KMIO 2015
Radiotherapy :  Past Present Future  KMIO 2015Radiotherapy :  Past Present Future  KMIO 2015
Radiotherapy : Past Present Future KMIO 2015
 
Radiation therapy in Cancer Oesophagus
Radiation therapy in Cancer Oesophagus Radiation therapy in Cancer Oesophagus
Radiation therapy in Cancer Oesophagus
 
EGFR in cervical cancer
EGFR in cervical cancerEGFR in cervical cancer
EGFR in cervical cancer
 
ABRAXANE in Radiation Therapy
ABRAXANE in Radiation TherapyABRAXANE in Radiation Therapy
ABRAXANE in Radiation Therapy
 
IMPROVISED RADIOTHERAPY TECHNIQUES IN TELE COBALT WITHOUT MLC
IMPROVISED RADIOTHERAPY TECHNIQUES IN TELE COBALT WITHOUT MLCIMPROVISED RADIOTHERAPY TECHNIQUES IN TELE COBALT WITHOUT MLC
IMPROVISED RADIOTHERAPY TECHNIQUES IN TELE COBALT WITHOUT MLC
 
Temozolomide As A Radiosensitizer Clinical Experience At Kmio
Temozolomide As A Radiosensitizer Clinical Experience At KmioTemozolomide As A Radiosensitizer Clinical Experience At Kmio
Temozolomide As A Radiosensitizer Clinical Experience At Kmio
 
Radiation Therapy In India
Radiation Therapy In IndiaRadiation Therapy In India
Radiation Therapy In India
 

Recently uploaded

Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Savita Shen $i11
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
Dr. Vinay Pareek
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
SumeraAhmad5
 
POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
touseefaziz1
 
THOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation ActTHOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation Act
DrSathishMS1
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
NephroTube - Dr.Gawad
 
Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...
Sujoy Dasgupta
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
Dr. Rabia Inam Gandapore
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
Krishan Murari
 
Antiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptxAntiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptx
Rohit chaurpagar
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
bkling
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Dr KHALID B.M
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
Swetaba Besh
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
د.محمود نجيب
 
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
Catherine Liao
 
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
Catherine Liao
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
GL Anaacs
 
The Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of IIThe Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of II
MedicoseAcademics
 
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyayaCharaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Dr KHALID B.M
 

Recently uploaded (20)

Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
 
heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
 
POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
 
THOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation ActTHOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation Act
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
 
Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
 
Antiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptxAntiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptx
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
 
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
 
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
 
The Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of IIThe Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of II
 
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyayaCharaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
 

Radiation therapy in prostate cancer

  • 1. Radiation Therapy in Prostate Cancer Lokesh Viswanath M.D. Professor, Radiation Oncology, Kidwai Memorial Institute of Oncology 2014
  • 2. Prostate Cancer • World wide : – Second most common cause of cancer – New Cases ~ 1.1 million (15%) – Developed countries ~ 70% – 307,000 deaths • Prostate cancer incidence – Lowest: • Asian populations 10.5 per 100,000 • Eastern and South-Central Asia 4.5 per 100,000 – Highest : • 111.6 Australia/New Zealand and • 97.2 per 100,000 Northern America
  • 3.
  • 4. In India • Previously – thought - prevalence of prostate cancer in India is far lower compared to western countries • but … – increased migration rural to urban areas – changing life styles – increased awareness – easy access to medical facility ….. – more cases of prostate cancer are being picked up – we are not very far behind the rate from western countries. – Current incidence rate of prostate cancer in India is ~ 10.66 per 100000 population
  • 5. Current India Data: • Prostate cancer: – 2nd leading site of - Delhi, Kolkatta, Pune and Thi'puram – 3rd leading site of Bangalore and Mumbai Projected cases of prostate cancer for selected time periods (2013, 2014, 2015 and 2020). ICD-10 Site name 2013 2014 2015 2020 C61 Prostate 35,029 37,055 39,200 51,979
  • 6. Prostate : Anatomy • Prostate – Accessory gland – Inverted Cone encompasses the p. urethra – Dense fibromuscular stroma – Surrounded by a capsule – 4 x 3 x 2cms – 8g • Prozimity to Rectum & U Bladder – Denonvilliers fascia • Blood supply – Inferior vesical – Mid rectal – Internal pudendal • Lymphatics – Internal iliac nodes – Sacral – Partly external iliac nodes Nervous supply – Neurovascular bundle • Lies on either side of the prostate on the rectum – Derived from the pelvic plexus - Important for erectile function.
  • 7. Epidemiology • Risk factors – Increasing age – Family history – African-American – Dietary factors. • Race – Incidence doubled in African Americans compared to white Americans. • Genetics – Common among relatives with early-onset prostate cancer – Susceptibility locus • Chromosome 1, band Q24 • Found in < 10% of prostate cancer patients • Nutritional factors - protective effect against prostate cancer – Reduced fat intake – Soy protein – Lycopene – Vitamin E – Selenium
  • 8. Clinical Manifestations : Symptoms • Early state (organ confined) – Asymptomatic • Locally advanced – Obstructive voiding symptoms • Hesitancy • Intermittent urinary stream • Decreased force of stream – May have growth into the urethra or bladder neck – Hematuria – Hematospermia • Advanced (spread to the regional pelvic lymph nodes) – Edema of the lower extremities – Pelvic and perineal discomfort
  • 9. Clinical Manifestations : 2 • of Metastasis : – Most commonly to bone (frequently asymptomatic) • Can cause severe and unremitting pain – Bone metastasis • Can result in pathologic fractures or • Spinal cord compression – Visceral metastases (rare) – Can develop pulmonary, hepatic, pleural, peritoneal, and central nervous system metastases late in the natural history or after hormonal therapies fail.
  • 10. Clinical Signs • Routine Clinical history and clinical examination Rectal examination • Signs: PR examination - Abnormal • ( +ve for Malignancy 25-50%) • Hard nodule / extremely firm • Evaluate for disease extension in – Lateral sulcus – superior
  • 11. Presentation • Peripheral zone (PZ) – 70% of cancers • Transitional zone (TZ) – 20% – Some • TZ prostate cancers are relatively nonaggressive • PZ cancers are more aggressive – Tend to invade the periprostatic tissues.
  • 12. Investigations Routine: Laboratory Complete blood cell count, blood chemistry Serum PSA (total, free, complex PSA:: ratio of Free : Total PSA < 0.2 - likely Prostate Ca. ) (Normal Age-Specific Limits for PSA - Plasma acid phosphatases (prostatic/total) Testosterone Other Experimental: RT PCR for mRNA of PSA & PSMA +ve - Extraprostatic – 72% -ve - Organ confined - 88%
  • 13. Staging Tests 1. Magnetic resonance imaging (MRI) – defn Apex, NV bundle, ano rectal wall, intra prostatic dises location, capsular extension, seminal vesicle involvement 1. T2 axial / coronal : neurovascular bundle , penile bulb 2. PZ - T2 Normal – high signal , Tumor – Low signal , T1 – Hemorrhage – Low signal intensity 3. Extracapsular extension : focal, irregular capsular bulge, invasion of NV bundle, obliteration of rectoprostatic angle 4. endorectal MRSI – MR spectroscopy : metabolic activity and extra capsular extension, seminal vesicle invasion : Increase coline 2. Transrectal ultrasound (TRUS) : » Ca – variable echo, hyper – 69%, margin - poorly defined , 3. Transrectal or transperineal biopsy : – 16 guage , 10 -18 core (base, apex, both lateral, mid, lat peripheral zone) – Core length 4. Chest radiograph (high risk for metastatic disease) 5. Computed tomography (CT) scans – pelvis node assesment 6. Radionuclide bone scans : Indicated: PSA>20, Gleason score ≥8, Bone pain Other: 1. PET/CT with 11C- Acetate - detecting microscopic +LN
  • 14. Others : essential base line evaluation • Erectile function • Bowel : SI/LI/Rectum/Anal Sphincters • Bladder : Flow/rate
  • 15. AJCC / TNM Stage Groupings Definitions
  • 16.
  • 17. Pathology • Adenocarcinoma 95% - peripheral acinar glands • Other Histologic Subtypes – Periurethral duct carcinoma – transitional cell carcinoma – Ductal adenocarcinoma – Neuroendocrine tumors – Mucinous carcinoma – Sarcomatoid carcinoma – Endometrioid tumors – Adenoid cystic carcinoma – Sarcomas (leiomyosarcoma, rhabdomyosarcoma, or fibrosarcoma) – Carcinosarcoma – Primary lymphoma
  • 18. Evaluation of the histologic grade ('G') GX: cannot assess grade G1: the tumor closely resembles normal tissue (Gleason 2–4) G2: the tumor somewhat resembles normal tissue (Gleason 5–6) G3–4: the tumor resembles normal tissue barely or not at all (Gleason 7–10)
  • 19. Gleason score • histological patterns, emphasizing degree of glandular differentiation and relation to stroma • Histologic patterns 1 through 5 • nine discrete scores (range, 2 to 10) • one of the strongest predictors of – biologic behavior in prostate cancer – invasiveness – metastatic potential – < 6
  • 20. Prostate Cancer Risk Groups :- stage : PSA : Gleason score
  • 21. Treatment options for prostate cancer • Observation alone • Radical prostatectomy • Radiation therapy • Hormonal treatment
  • 22. Overview Treatment Options by Stage for Prostate Cancer Stage ( AJCC TNM Staging Criteria) Standard Treatment Options Stage I •Watchful waiting or active surveillance •Radical prostatectomy •External-beam radiation therapy (EBRT) •Interstitial implantation of radioisotopes Stage II •Watchful waiting or active surveillance •Radical prostatectomy •External-beam radiation therapy (EBRT) with or without hormonal therapy •Interstitial implantation of radioisotopes Stage III •External-beam radiation therapy (EBRT) with or without hormonal therapy •Hormonal manipulations (orchiectomy or luteinizing hormone-releasing hormone [LH-RH] agonist) •Radical prostatectomy with or without EBRT •Watchful waiting or active surveillance Stage IV •Hormonal manipulations •Bisphosphonates •External-beam radiation therapy (EBRT) with or without hormonal therapy •Palliative radiation therapy •Palliative surgery with transurethral resection of the prostate (TURP) •Watchful waiting or active surveillance Recurrent •Chemotherapy for hormonal management of prostate cancer •Immunotherapy
  • 23. Indications for RT T N0 N1 M1 PSA GS SURVELLI ANCE SURGERY Radical RT Radical Brachytherapy HT T1a + <10 <6 YES RP+ PLND RT BRACY T1b + <10 <6 YES RP+ PLND (<2% +ve nodes) RT BRACY T1c + <10 <6 YES RP+ PLND (>2% +ve nodes) RT BRACY T2a + RT + ADT T2b + RT + ADT T2c + 10 to 20 7 YES RP+ PLND RT + ADT + BRACHY BOOST BRACY Y T3a + >20 8 to 10 RP+ PLND RT + ADT BRACHY BOOST Y T3b + RT + ADT BRACHY BOOST Y T4 + RT + ADT BRACHY BOOST ADT Any T + RT + ADT Y Any T / N + RT ADT
  • 26. • Radiation therapy is the art of using ionising radiation to destroy malignant tumours while being able to minimise damage to normal tissue.
  • 27. Introduction • Basics of Radiation Therapy – Ionizing Radiation – X / γ Rays – Interaction of Radiation with matter Transmission Attenuation Scatter Absorption Rad / Gray / cGy
  • 28. Cancer Cell & Ionizing Radiation • Cancer cell multiply faster than normal cell • DNA is primary target • Double Strand breaks >>> Reproductive Cell Death
  • 29. RT is a Double Edge Sword
  • 30. ↑ RT Dose ↓ RT Dose ↑ T – Control ↓ T – Control ↑ Normal Tissue Toxicitites ↓ Normal Tissue Toxicitites
  • 32. Radiation Equipments Teletherapy • Telecobalt • Linear Accelerator – Simple Teletherapy – SRS/SRT – 2D – 3DCRT – IMRT – IGRT – Rapid Arc – FFF – SBRT – 4DRT – Target tracking – Tomotherapy – Cyber Knife • Gamma Knife Brachytherapy – Intracavitory – Interstitial – Mould • Pre Loaded / After loading • Manual / Remote • LDR / HDR • Permanent Implants
  • 33. Linear Accelerator • 3DCRT > 1998+ • IMRT > 2000+
  • 34. Linear Accelerator : 3DCRT / IMRT
  • 36. Synchrony™ camera Cyber Knife – 2003+ Treatment couch Linear accelerator Targeting System Manipulator Image detectors X-ray sources Robotic Delivery System
  • 38. True beam - All in One FFF SBRT / 4DRT –
  • 39. True Beam - 2010
  • 41. Brachytherapy • LDR - Iridium wires – Manual Interstitial <Phased out> • HDR – Iridium / Cobalt • Permanent Interstitial Implant – Iodine seeds
  • 42. 125 I Seed Implant
  • 45. Radiation Therapy Prostate Cancer : • Disease Characterization : • Clinical - KPS/Co-existing Morbidities/TRUS/ CT/MR • TNM/PSA/GS – Primary – Primary + Regional nodes • + ADT PSA (ng/ml) +VE PELVIC NODE YEILD 4-20 < 12% >20 > 10% > 25 30-35% > 50 + high GS 62%
  • 46. Radiation Therapy : Intent Defn • Radical RT – RT alone: – Conventional (7-8 weeks) < – Hyperfractionation (5-6 weeks) – Hypofractionation (1-2 Gap 1-2 weeks) < CK / SRS / SBRT – Photons alone – Recent adv - Photons + Particle (Protons) – Protons alone – RT + Hormon therapy (HT) – RT + Radiation Protectors (Amifostine) – Teletherapy + Brachytherapy Boost – Brachytherapy alone • Brachy type: Volume implants – Temporary Implant – HDR – Permanaent Implant – I 125 • Post Operative RT (5-7 weeks) • Salvage RT / Re-irradiation • Palliative RT – Short Course (1day, 1-2 weeks) – Saturation Technique (1-2 weeks gap 3-4 weks)
  • 47. RT Techniques • Teletherapy – 2 D – 3 D Conformal – IMRT – IGRT – Tomotherapy – CK SRS / SRT – Rapid arc – SBRT - FFF – Proton • Bracytherapy – Interstital • HDR – Ir - Temporary • 125 Iodine - Permanent
  • 48. Indications for RT in Ca Prostate • Radical RT – T1, T2, T3, T4a • Un-resectable (Altered Fractionation HF/CB or RT + HT ) • elderly, frail, comorbid conditions • refusal for surgery • prohibitive morbidity due to surgery • Post OP RT : after Radical Prostatectomy – pT3/4 – Close & +ve margin – Extra Capsular extension – Invasion to • Seminal vesicle • Extraprostatic extensions – Multiple nodes – R 1 resection • Pre OP PSA > 10ng/ml • Pre OP PSA velocity > 2ng/ml/year – Post RP – Recurrent disease – Post RP - early PSA failures
  • 49. RADIOTHERAPY DOSE 1. External : a. IMRT / IGRT / Rapid Arc / Protons : – > 7400 cGy to 7600 cGy / 6-8 wks – 180-200cGy / fr, 5fr/wk b. CK / SBRT / FFF : 5 – 20 Gy / fr, 3-5 fr c. Post-op.: 60-66 Gy / 6-7 wks d. Palliative RT: 30Gy/10f, 20Gy/5 or 4f, 7-8Gy/1f 2. Brachytherapy : a. Alone : 6000 - 7000 cGy in 6 to 7 days. b. External + Brachytherapy Ext : 46-50 Gy in 4 1/2 - 5 1/2 wks. + Brachy : 2000-3000 cGy in 2-3 days HDR : 9.5Gy x 2f, as mono therapy 9.5Gy bid x 4f x 2dys I -125 : 0.2-0.9mCi, T1/2-17dy, 21Kev
  • 50. RT Dose • 2D : 66Gy , 1.8-2Gy/f, 5f/wk • 3DCRT : 70-75Gy • IMRT /IGRT : 75 – 81Gy
  • 52. RT Planning • Informed Consent : • Implant Fidutial - +/- (if GC is not favorable CBCT ) • Mould room work : Patient positioning, knee rest • Virtual CT Simulation • Contouring • RT planning • Plan evaluation and acceptance • QA tests
  • 53. Fidutial Placement • TRUS Guided • 1 week prior to simulation
  • 54. Flat Couch CT Simulator
  • 55. Instructions for Virtual Simulation Mould room techniques: • Bowel / Bladder – post void (full – if u/s Tracking) • Patient Positioning : Supine (↓ P motion) / Prone • Thermoplastic mold – Pelvic cast - knee to mid thigh + Tattooe / Tegaderm • Knee rest Virtual simulation : Flat Couch – Patient repositioning – Pelvis : pubic symphysis - Laser set (mid / 2 lateral – 5cms post) – marking – Radio-opaque markers – CT Sim - 3mm – Scan : 20-30 cms above & 20-30 cms below the marker plane
  • 56. Contouring • Data transfer : from CT sim to RT planning system – DICOM format • Patient registration : CT data / CT + MR Fusion data • Contouring : Target & Normal tissue – CTV – P alone / P + SV / P + SV + Pelvic Ly nodes – PTV – CTV + Margin • Cobalt / 2D / 3DCRT - 2cms • IMRT – 1cms (in all directions except rectal interface – 0.6cms) • IGRT – 0.6 cms all round • CK/SBRT – 0.3 cms all round – Prostatic apex definition – urethrogram / MRI
  • 57. On the machine • Machine QA for the Planned treatment • Patient positioning and verification • Portal Imaging & setup verification + CBCT • Treatment plan execution • Daily QA • Daily Portal imaging /MV – KV / CBCT / 3D CBCT • Monitoring of Acute radiation reaction and supportive cares
  • 58.
  • 59. Beam selection and planning • 2 D : – AP: PA – AP : PA : RT Lat : Lt Lat • 3 DCRT : 6 Coplanar ( 2 – lat, 2 Ant & 2 Post Obliques ) – Plan evaluation : • Dose distribution (isocentre) – Transverse / Coronal / Sagittal • DVH • Beam weighing – 2 lat – half the dose • Uniform dose in PTV • Elimination of hot spot from rectum • Plan normalization : • Prescription iso-dose – 100% coverage of PTV • PTV Hot spot < 6-9% • Rectal volume in PTV 75.6G < 30% • Femur < 68Gy (90%) • Large bowel < 60Gy (79%) • Small bowel < 50 gy (66%)
  • 60. 2D plan – Orthogonal X Ray simulation
  • 61. • 3DCRT MLC based conformal field
  • 62.
  • 63.
  • 64. Evolution of conformality 2D RT 3DCRT IMRT Rapid Arc
  • 65.
  • 69.
  • 70.
  • 71.
  • 72.
  • 73.
  • 74.
  • 77. Proton Therapy vs. IMRT  Dosimetric study:  10 IMRT vs.10 proton beam to 78 Gy  Mean rectal dose-volume histograms Vargas et al. IJROBP 2007
  • 82. Prostate Brachytherapy Iodine 125 t ½ = 60 days Gamma emitter Energy 35 kV
  • 83.
  • 84.
  • 86. Target Motion ITV Management • Daily localization IGRT techniques to account for interfraction motion: – intraprostatic fiducial markers with daily imaging – transabdominal US – daily in-room CT imaging – endorectal balloon immobilization • All of these methods employ daily imaging of the prostate in the treatment room.
  • 87. Target Tracking • During RT – Celing mounted Cross fired X-Ray / Fluro eg.CK, X Tack – • Before RT – Orthogonal KV / MV Portal imaging – best with fidutial – CBCT / Onrail CT – suitable for patients without fidutials
  • 88. Ceiling mounted Cross fired X Rays
  • 89. Motion Management reference (simulation film) online (port film) co-registered (right) In this technique, the isocenter is shifted until the bony contours (setup error) or the implanted markers are in agreement (total error).
  • 90. Motion Management  Cone beam computerized tomography (CBCT) allows volumetric visualization of the prostate and adjacent organs. – Daily online correction allows for PTV margins: • 4 mm in all directions and 3 mm posterior (Pawlowski, Red Journal 2010) • 5 mm all around and 3 mm posterior (Hammoud, Red Journal 2008) 2 stages of image registration: Top: pelvic bone region of interest Bottom: prostate/sv represented by masked area.
  • 91. Motion Management • Intrafraction Motion – Changes in position while the treatment beam is on (“second by second”) – Mostly from peristalsis/gas, pelvic floor movement, respiration coughing, etc. – Techniques to account for intrafraction motion: • RGRT (radiofrequency-guided RT techniques) • Rectal balloon • Bowel prep (anti-gas tablets and daily bm) • Consistent Bladder filling
  • 92.
  • 93.
  • 94.
  • 95.
  • 96.
  • 97.
  • 98.
  • 99.
  • 100.
  • 101. Motion management  Endorectal balloon – Used for prostate immobilization/fixation – Ensures reproducibility of rectal filling and spares posterior rectum Teh, Red Journal 2001 78 Gy IMRT plans without (left) and with balloon (right) Contours: rectal wall (green), anal wall (purple) and PTV (blue).
  • 103. PSA relapse free survival rate (%) ~ EBRT RP BRACHY 5 YRS 79 81 98 8 YRS 70 72 92
  • 104.
  • 105. androgen suppression or androgen deprivation therapy.
  • 106. most commonly used hormone therapies • Orchiectomy Medical Castration - reversible • luteinizing hormone-releasing hormone (LHRH) agonists – synthetic proteins - similar to LHRH and bind to the LHRH receptor in the pitutary gland- causes the pituitary gland to stop producing luteinizing hormone, which prevents testosterone from being produced- leuprolide, goserelin, and buserelin • LHRH antagonists - act by preventing LHRH from binding to its receptors in the pitutary gland
  • 107. Toxicities Impotence rates • Brachy alone – 24% • Brachy + EBRT – 40% • EBRT alone – 45% • Nerve sparing RP – 66% • RP – 75% • Cryosurgery – 87% Urinary control • RP – 35% • RT – 97%
  • 109. Advances in newer radiation technologies • Enhanced Normal Tissue Sparing • Reduces side effects • Dose Escalation has Improved Cure Rate • Higher Dose per Fraction reduces hospital visits • Reduce Number of fractions • Reduce Treatment Duration